Celon Pharma S.A. Logo

Celon Pharma S.A.

CLN | WAR

Overview

Corporate Details

ISIN(s):
PLCLNPH00015 (+3 more)
LEI:
259400Q0ERJT0NC5DT24
Country:
Poland
Address:
KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Celon Pharma S.A. is an integrated biopharmaceutical company established in 2002 that specializes in the research, development, manufacturing, and marketing of pharmaceuticals. The company's portfolio includes both generic and innovative drugs. Its research and development efforts are focused on creating novel therapeutic solutions, with a particular emphasis on treatments for neurological diseases and cancer. As an integrated entity, Celon Pharma manages the entire drug lifecycle, from initial scientific discovery and clinical trials to production and commercial distribution, aiming to improve patient quality of life.

Social Media

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for Celon Pharma S.A.. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-04 15:16
Capital/Financing Update
Uzgodnienie z Europejskim Bankiem Odbudowy i Rozwoju głównych warunków udzielen…
Polish 1.5 KB
2025-07-16 21:15
Major Shareholding Notification
zal01_TCM_Celon_Notification_Form.pdf
English 89.7 KB
2025-07-16 21:15
Major Shareholding Notification
Otrzymanie zawiadomienia o przekroczeniu progu 5% udziału w ogólnej liczbie gło…
Polish 1.1 KB
2025-06-26 21:39
Post-Annual General Meeting Information
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 888 bytes
2025-06-26 21:36
Post-Annual General Meeting Information
Uchwały podjęte przez ZWZ
Polish 221.8 KB
2025-06-26 21:36
Post-Annual General Meeting Information
Uchwały podjęte przez Zwyczajne Walne Zgromadzenie Celon Pharma S.A. w dniu 26 …
Polish 559 bytes
2025-06-03 09:16
Regulatory News Service
Przekazanie informacji o wprowadzeniu produktu leczniczego TIKOZEK do regulator…
Polish 1021 bytes
2025-05-30 17:57
Remuneration Information
zal05_Sprawozdanie_o_wynagrodzeniach_Czlonkow_Zarzadu_i_RN_Celon_Pharma_SA_za_2…
Polish 274.1 KB
2025-05-30 17:57
Remuneration Information
zal04_Projekt_Polityka_Wynagrodzen_zalacznik_do_uchwaly_nr_17_ZWZ_Celon_Pharma_…
Polish 149.4 KB
2025-05-30 17:57
Board/Management Information
zal03_Celon_Pharma_Sprawozdanie_Rady_Nadzorczej_za_2024.pdf
Polish 672.4 KB
2025-05-30 17:57
Pre-Annual General Meeting Information
zal01_Celon_Pharma_Projekty_uchwal_na_ZWZ_26_06_2025.pdf
Polish 258.6 KB
2025-05-30 17:57
Pre-Annual General Meeting Information
zal02_Celon_Pharma_Ogloszenie_o_zwolaniu_ZWZ_26_06_2025.pdf
Polish 243.1 KB
2025-05-30 17:57
Pre-Annual General Meeting Information
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Celon Pharma S.A. na dzi…
Polish 2.7 KB
2025-05-21 17:05
Quarterly Report
Raport za 1 kwartał 2025
Polish 2.0 MB
2025-05-06 15:48
Legal Proceedings Report
Podpisanie umowy o objęcie wsparciem projektu Celon Pharma S.A. w ramach Krajow…
Polish 2.9 KB

Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK